STEPHANIE MCLAIN: Open Payments
NPI 1548954878 · QUEENSBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 17 payments from 10 companies in 2025. Trend: 2023 $66 · 2024 $512 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $20 |
| CVRx, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: CAMZYOS, VERQUVO, JARDIANCE, OPSUMIT, Attruby, Barostim Neo System, ONPATTRO, FUROSCIX.
Industry payments across NY — which companies pay providers there.
